August 7, 2018 08:44 AM EDT
People
Bioregnum
Opinion

GSK chief Em­ma Walm­s­ley rounds out her top team with CFO pick — but per­for­mance lags

Glax­o­SmithK­line CEO Em­ma Walm­s­ley is reach­ing in­to the glob­al bank­ing world to fin­ish round­ing out the top team she ex­pects to re­verse the phar­ma gi­ant’ …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
TRENDING NOW

J&J part­ners on STAT6; As­traZeneca, Dai­ichi with­draw lung can­cer drug EMA app

FDA ap­proves sub­cu­ta­neous ver­sion of Bris­tol My­er­s' Op­di­vo

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

BioN­Tech set­tles with NIH, UPenn in Covid vac­cine dis­putes and will pay roy­al­ties

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

A service from the Financial Times